Develops precision medicines targeting molecular drivers of tumor progression, metastasis, and multi-drug resistance. Lead therapeutics aim to halt progression at any cancer stage, synergize with standard-of-care to overcome resistance, and eradicate primary and metastatic lesions in cancer patients.